Cases & Deals

Cellnovo completes €17.5 million private placement of new shares

Clients Cellnovo Group

Jones Day advised Cellnovo, a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, listed on the regulated market of Euronext in Paris, and Oddo BHF in connection with the €17.5 million (US$19.9 million) private placement of Cellnovo new shares to European investors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.